Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin W Howden

Showing results (41-50 of 170) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|December 17, 2020
A Message from the EditorsJonathan M Rhodes, Colin W Howden
Gastroenterology|July 16, 2019
ReplyM Scott Harris, Colin W Howden
Gastroenterology|March 7, 2018
Meeting Report: AGA Biosimilars RoundtableColin W Howden, Gary R Lichtenstein
Gastroenterology|February 2, 2017
Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development ConferenceColin W Howden, Nimish B Vakil
Current Gastroenterology Reports|July 16, 2008
Potential adverse effects of proton pump inhibitorsGregory A Coté, Colin W Howden
Current Gastroenterology Reports|November 6, 2004
Is no NSAID a good NSAID? Approaches to NSAID-associated upper gastrointestinal diseaseStephen Y Chang, Colin W Howden
Gastroenterology Clinics of North America|May 19, 2009
The role of proton pump inhibitors in the management of upper gastrointestinal bleedingGrigorios I Leontiadis, Colin W Howden
The American Journal of Gastroenterology|September 14, 2006
To establish the efficacy of PPI therapy for ulcer bleeding in the United States, do we need more patients or more PPI [corrected]Grigoris I Leontiadis, Colin W Howden
The American Journal of Gastroenterology|December 30, 2020
Recent Developments Pertaining to H. pylori InfectionColin W Howden, David Y Graham
Alimentary Pharmacology & Therapeutics|October 27, 2023
Editorial: PPIs and gastric cancer-Are we dealing with a carcinogen?Peter Malfertheiner, Christian Schulz, Colin W Howden
Pageof 17

Showing results (41-50 of 170) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|December 17, 2020
A Message from the EditorsJonathan M Rhodes, Colin W Howden
Gastroenterology|July 16, 2019
ReplyM Scott Harris, Colin W Howden
Gastroenterology|March 7, 2018
Meeting Report: AGA Biosimilars RoundtableColin W Howden, Gary R Lichtenstein
Gastroenterology|February 2, 2017
Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development ConferenceColin W Howden, Nimish B Vakil
Current Gastroenterology Reports|July 16, 2008
Potential adverse effects of proton pump inhibitorsGregory A Coté, Colin W Howden
Current Gastroenterology Reports|November 6, 2004
Is no NSAID a good NSAID? Approaches to NSAID-associated upper gastrointestinal diseaseStephen Y Chang, Colin W Howden
Gastroenterology Clinics of North America|May 19, 2009
The role of proton pump inhibitors in the management of upper gastrointestinal bleedingGrigorios I Leontiadis, Colin W Howden
The American Journal of Gastroenterology|September 14, 2006
To establish the efficacy of PPI therapy for ulcer bleeding in the United States, do we need more patients or more PPI [corrected]Grigoris I Leontiadis, Colin W Howden
The American Journal of Gastroenterology|December 30, 2020
Recent Developments Pertaining to H. pylori InfectionColin W Howden, David Y Graham
Alimentary Pharmacology & Therapeutics|October 27, 2023
Editorial: PPIs and gastric cancer-Are we dealing with a carcinogen?Peter Malfertheiner, Christian Schulz, Colin W Howden
Pageof 17